Shares of hVIVO plc (LON:HVO – Get Free Report) traded down 6.8% during trading on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares changed hands during mid-day trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Price Performance
The firm has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The firm’s fifty day simple moving average is GBX 23.58 and its 200 day simple moving average is GBX 26.77. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- How to Capture the Benefits of Dividend Increases
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Differences Between Momentum Investing and Long Term Investing
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is MarketRank™? How to Use it
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
